Tremfya goes for psoriatic arthritis

[Fred]

Johnson & Johnson files with U.S. Food and Drug Administration (FDA) to include new evidence in Tremfya (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active psoriatic arthritis.

Quote:

---

Johnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval to include new evidence in the TREMFYA® (guselkumab) label for the inhibition of progression of structural damage in adults with active psoriatic arthritis (PsA).

The submission is supported by the Phase 3b APEX study in patients with active PsA, which achieved both its primary endpoint of reducing joint symptoms (ACR20) and its major secondary endpoint of inhibited progression of structural damage as measured by change in the modified van der Heijde-Sharp (vdH-S) score at 24 weeks, compared to placebo in bio-naïve patients.

Data from the APEX study were consistent with the well-established safety profile of TREMFYA®. Additional data will be presented at future medical meetings.

TREMFYA® is the first and only fully-human, dual-acting monoclonal antibody approved to treat PsA that blocks IL-23 while also binding to CD64, a receptor on cells that produce IL-23. IL-23 is a cytokine secreted by activated monocyte/macrophages and dendritic cells that is known to be a driver of immune-mediated diseases including active PsA.

Tremfya (guselkumab)

Source: jnj.com

[Caroline]

It becomes clearer that inhibition of either one of the IL-23 or IL-17’s leads to less psoriasis and Psoriatic Arthritis.

It in fact suggests that both interleukines do have a connection to each other and it strongly again suggests that both disease are really the same.
Psoriatic Arthritis is not just a form of Rheuma, but a form of psoriasis and should be treated differently.

[Fred]

It becomes clearer that inhibition of either one of the IL-23 or IL-17’s leads to less psoriasis and Psoriatic Arthritis.

It in fact suggests that both interleukines do have a connection to each other and it strongly again suggests that both disease are really the same.
Psoriatic Arthritis is not just a form of Rheuma, but a form of psoriasis and should be treated differently.

I agree